University of Münster
CRIS@UM
DE | EN

Dr. Tobias Kewitz

No current affiliations available for this person. The person is no longer active at the university.

Publications

A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
Berdel AF, Koch R, Gerss J, Hentrich M, Peceny R, Bartscht T, Steffen B, Bischoff M, Spiekermann K, Angenendt L, Mikesch JH, Kewitz T, Butterfass-Bahloul T, Serve H, Lenz G, Berdel WE, Krug U, Schliemann C (2023)
In: Annals of Hematology, 102, 63-72. doi:10.1007/s00277-022-05025-0
Research article (journal) | Peer reviewed | Published